Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | PGK1 | P00558 | 1/20 | 0.40 |
| ▸ | PGK2 | P07205 | 1/20 | 0.40 |
| ▸ | MVD | P53602 | 1/20 | 0.40 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11386950 | 0.98 | LPAR3 (0.48) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL21121925 | 0.93 | ALDH1A1 (0.56) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL4535481 | 0.91 | ALDH1A1 (0.59) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL4536951 | 0.91 | ALDH1A1 (0.59) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL4520895 | 0.91 | ALDH1A1 (0.59) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL10545856 | 0.91 | ALDH1A1 (0.54) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL4516204 | 0.91 | ALDH1A1 (0.59) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL4517953 | 0.91 | ALDH1A1 (0.59) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL4529208 | 0.91 | ALDH1A1 (0.59) | LPAR3LPAR2LPAR1ALDH1A1LMNA | |
| SCHEMBL4525157 | 0.91 | ALDH1A1 (0.59) | LPAR3LPAR2LPAR1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2872514-B1 | IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-08-30 | — | — | EP | claimed |
| EP-4605393-A1 | TRIAZOLE-SUBSTITUTED IMIDAZO[1,2-A]PYRIMIDINES AS CGAS INHIBITORS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2025-08-27 | — | — | EP | disclosed |
| WO-2025095130-A1 | BATTERY PACK AND SPACER | 三菱ケミカル株式会社 | 2025-05-08 | — | — | WO | disclosed |
| WO-2024083773-A1 | TRIAZOLE-SUBSTITUTED IMIDAZO[1,2-A]PYRIMIDINES AS CGAS INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2024-04-25 | — | — | WO | disclosed |
| US-11788055-B2 | Materials and methods for controlling oxidation and reduction in biosynthetic pathways of species of the genera ralstonia and cupriavidus and organisms related thereto | INV NYLON CHEMICALS AMERICAS, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| CN-113423685-A | Prodrug modulators of integrated stress pathways | 卡里科生命科学有限责任公司 | 2021-09-21 | — | — | CN | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| CN-104685058-B | Microorganisms and methods for making 4-hydroxybutyrate, 1, 4-butanediol, and related compounds | 基因组股份公司 | 2020-07-07 | — | — | CN | disclosed |
| US-20190338375-A1 | MATERIALS AND METHODS FOR CONTROLLING OXIDATION AND REDUCTION IN BIOSYNTHETIC PATHWAYS OF SPECIES OF THE GENERA RALSTONIA AND CUPRIAVIDUS AND ORGANISMS RELATED THERETO | INV NYLON CHEMICALS AMERICAS, LLC | 2019-11-07 | — | — | US | disclosed |
| WO-2019055754-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| EP-2872514-A1 | IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014011974-A1 | IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-01-16 | — | — | WO | disclosed |
| CN-102625845-A | Microorganisms and methods for the synergistic production of isopropanol and primary alcohols, glycols and acids | GENOMATICA INC | 2012-08-01 | — | — | CN | disclosed |
| US-20090220431-A1 | MAGNETIC RESONANCE IMAGING CONTRAST AGENTS CONTAINING WATER-SOLUBLE NANOPARTICLES OF MANGANESE OXIDE OR MANGANESE METAL OXIDE | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2009-09-03 | — | — | US | disclosed |
| WO-2007064175-A1 | MAGNETIC RESONANCE IMAGING CONTRAST AGENTS CONTAINING WATER-SOLUBLE NANOPARTICLES OF MANGANESE OXIDE OR MANGANESE METAL OXIDE | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2007-06-07 | — | — | WO | disclosed |